Biotech RadarJobs updated

COMPANY

Reveal Pharmaceuticals Inc.

revealpharma.com ↗

Clinical Phase 2

Also known as Reveal Pharmaceuticals · 2 sources

Profile checked Oct 10, 2026

Keywords: Brain Tumors Central Nervous System (CNS) Lesions Brain Metastases Brain Neoplasms Benign Brain Neoplasms Primary Brain Tumor Recurrent Brain Tumor Brain Cancer Primary Brain Neoplasm Multiple Sclerosis Multiple Sclerosis Brain Lesion Neurofibroma Acoustic Neuroma CNS Tumor CNS Lesion CNS Metastases CNS Cancer CNS Lymphoma Von Hippel Lindau Meningioma Glioma Schwannomas Neuroinflammation Neoplasia RVP-001

2Trials (company is sponsor)

Timeline

  1. Trial start 2: Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent source ↗
  2. Trial start Phase 1: First in Human Study of RVP-001, a New Manganese Based MRI Contrast Agent source ↗

Clinical trials (lead sponsor) 2

RecordTitlePhaseStatusStartPrimary completion
NCT06322342Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent2CompletedAug 15, 2024Dec 19, 2025 (actual)
NCT05413668First in Human Study of RVP-001, a New Manganese Based MRI Contrast AgentPhase 1CompletedMay 18, 2022Jul 22, 2022 (actual)
Feedback